These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 34312902)

  • 21. An overview of optimal designs under a given budget in cluster randomized trials with a binary outcome.
    Liu J; Liu L; James AS; Colditz GA
    Stat Methods Med Res; 2023 Jul; 32(7):1420-1441. PubMed ID: 37284817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Efficient treatment allocation in two-way nested designs.
    Lemme F; van Breukelen GJ; Berger MP
    Stat Methods Med Res; 2015 Oct; 24(5):494-512. PubMed ID: 24030312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Minimisation for the design of parallel cluster-randomised trials: An evaluation of balance in cluster-level covariates and numbers of clusters allocated to each arm.
    Martin J; Middleton L; Hemming K
    Clin Trials; 2023 Apr; 20(2):111-120. PubMed ID: 36661245
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Explaining the variation in the attained power of a stepped-wedge trial with unequal cluster sizes.
    Ouyang Y; Karim ME; Gustafson P; Field TS; Wong H
    BMC Med Res Methodol; 2020 Jun; 20(1):166. PubMed ID: 32580698
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cluster randomised trials with different numbers of measurements at baseline and endline: Sample size and optimal allocation.
    Copas AJ; Hooper R
    Clin Trials; 2020 Feb; 17(1):69-76. PubMed ID: 31580144
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficient design of cluster randomized and multicentre trials with unknown intraclass correlation.
    van Breukelen GJ; Candel MJ
    Stat Methods Med Res; 2015 Oct; 24(5):540-56. PubMed ID: 21937473
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of complex, partially nested clustering in a three-arm individually randomized group treatment trial: A case study with the wHOPE trial.
    Tong G; Seal KH; Becker WC; Li F; Dziura JD; Peduzzi PN; Esserman DA
    Clin Trials; 2022 Feb; 19(1):3-13. PubMed ID: 34693748
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Practical considerations for sample size calculation for cluster randomized trials.
    Leyrat C; Eldridge S; Taljaard M; Hemming K
    J Epidemiol Popul Health; 2024 Feb; 72(1):202198. PubMed ID: 38477482
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Maximin optimal designs for cluster randomized trials.
    Wu S; Wong WK; Crespi CM
    Biometrics; 2017 Sep; 73(3):916-926. PubMed ID: 28182835
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sample size calculation for stepped wedge and other longitudinal cluster randomised trials.
    Hooper R; Teerenstra S; de Hoop E; Eldridge S
    Stat Med; 2016 Nov; 35(26):4718-4728. PubMed ID: 27350420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A tutorial on sample size calculation for multiple-period cluster randomized parallel, cross-over and stepped-wedge trials using the Shiny CRT Calculator.
    Hemming K; Kasza J; Hooper R; Forbes A; Taljaard M
    Int J Epidemiol; 2020 Jun; 49(3):979-995. PubMed ID: 32087011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Substantial risks associated with few clusters in cluster randomized and stepped wedge designs.
    Taljaard M; Teerenstra S; Ivers NM; Fergusson DA
    Clin Trials; 2016 Aug; 13(4):459-63. PubMed ID: 26940696
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sample size calculations for cluster randomised controlled trials with a fixed number of clusters.
    Hemming K; Girling AJ; Sitch AJ; Marsh J; Lilford RJ
    BMC Med Res Methodol; 2011 Jun; 11():102. PubMed ID: 21718530
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficient treatment allocation in 2 × 2 cluster randomized trials, when costs and variances are heterogeneous.
    Lemme F; van Breukelen GJ; Berger MP
    Stat Med; 2016 Oct; 35(24):4320-4334. PubMed ID: 27271007
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sample size calculation in cost-effectiveness cluster randomized trials: optimal and maximin approaches.
    Manju MA; Candel MJ; Berger MP
    Stat Med; 2014 Jul; 33(15):2538-53. PubMed ID: 25019136
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Unequal cluster sizes for trials in English and Welsh general practice: implications for sample size calculations.
    Kerry SM; Bland JM
    Stat Med; 2001 Feb; 20(3):377-90. PubMed ID: 11180308
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal designs in three-level cluster randomized trials with a binary outcome.
    Liu J; Liu L; Colditz GA
    Stat Med; 2019 Sep; 38(20):3733-3746. PubMed ID: 31162709
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intracluster correlation adjustments to maintain power in cluster trials for binary outcomes.
    Chakraborty H; Moore J; Hartwell TD
    Contemp Clin Trials; 2009 Sep; 30(5):473-80. PubMed ID: 19386285
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.